Shirley A. Weis - May 18, 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol: MD
Transactions as of: May 18, 2023
Transactions value $: -$257,531
Form type: 4
Date filed: 5/22/2023, 05:00 PM
Previous filing: May 15, 2023
Next filing: May 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	-$244K	-18K	-49.07%	$13.55	18.7K	May 18, 2023	Direct	F1
transaction	MD	Common Stock	Sale	-$13.7K	-1.01K	-5.39%	$13.63	17.7K	May 19, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $13.54 to $13.58 for a weighted average sales price of $13.55. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $13.63 to $13.64 for a weighted average sales price of $13.63. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $13.54 to $13.58 for a weighted average sales price of $13.55. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $13.63 to $13.64 for a weighted average sales price of $13.63. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.